Litigation over the abortion pill mifepristone is set to continue after a federal judge on Thursday issued an order allowing a group of Republican-led states to file an amended complaint against FDA regulations.
The Food and Drug Administration and mifepristone manufacturer Danco Laboratories failed to show that a lawsuit from Idaho, Kansas, and Missouri wouldn’t survive a motion to dismiss, Judge Matthew Kacsmaryk of the US District Court for the Northern District of Texas wrote in his order. Kacsmaryk previously allowed the states to intervene in the case initially brought by anti-abortion doctors.
The US Supreme Court in June ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.